(A) Cultures of wt, NRG1 type III+/−, and NRG1 type III−/− neurons were incubated with erbB2/3-Fc and then fixed and visualized with rhodamine-conjugated anti-human Fc antibodies (Aa–Ac); neurofilament staining from the corresponding fields is shown (Ad–Af). ErbB2/3-Fc binds strongly to wt (Aa), modestly to NRG1 type III+/− (Ab), and not at all to NRG1 type III−/− neurons (Ac). Scale bar, 40 μm.
(B) Membranes prepared from wt, NRG1 type III+/−, and NRG1 type III−/− neurons were centrifuged onto Schwann cell cultures, and after 20 min, lysates were prepared, blotted, and probed for phospho-Akt, total Akt, and phospho-erk as shown.
(C) NRG levels were assayed in culture media from wt, NRG1 type III+/−, and NRG1 type III−/− neurons by measuring erbB receptor phosphorylation in L6 myotubes. A representative Western blot revealing erbB receptor phosphorylation is shown. Following the phosphotyrosine (pY) Western blot, the membrane was stripped and reprobed for total erbB. The ratio of pY to total erbB is a quantitative measure of the amount of NRG in the media. Results from two separate experiments are shown below (mean ± SD).
(D) Rat DRG neurons were nucleofected with HA-tagged NRG1 type III (Da–Dc) or type I (Dd–Di) constructs were stained for HA (Da, Dd, and Dg) and peripherin (Db, De, and Dh); merged images (Dc, Df, and Di) are also shown. NRG1 type III is expressed at the axon surface (Da), whereas type I NRG1 is detectable at the surface of neurons treated for 48 hr with the MMP inhibitor GM 6001 (Dg) but not in untreated cultures (Dd). Scale bar, 40 μm.